Brief Summary
Type:
Multiple Myeloma
Study Type:
Treatment
Phase:
II
ClinicalTrials.gov Identifier:
NCT03548207
Study #:
STUDY00147913
Start Date:
Jun 14, 2022
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT03548207
View Complete Trial Details & Eligibility at ClinicalTrials.gov
